Foghorn Therapeutics (FHTX) Invested Capital (2019 - 2021)
Foghorn Therapeutics' (FHTX) quarterly Invested Capital came in at $300000.0 in Q2 2021, little changed quarter-over-quarter from $300000.0 in Q1 2021.
Foghorn Therapeutics (FHTX) Invested Capital (2019 - 2021) Analysis & Trends
Foghorn Therapeutics' Invested Capital history runs 3 years deep, the most recent figure standing at $300000.0 for Q2 2021.
- On a quarterly basis, Invested Capital changed N/A year-over-year to $300000.0 in Q2 2021; TTM through Mar 2022 was $300000.0, a 95.23% decrease from a year earlier, with the FY2019 full-year figure at $4.2 million, changed N/A from the prior year.
- Invested Capital held at $300000.0 in Q2 2021 per FHTX's latest filing, from $300000.0 in the prior quarter.
- Across five years, Invested Capital topped out at $6.0 million in Q3 2020 and bottomed at $300000.0 in Q1 2021.
- The 3-year median for Invested Capital is $2.2 million (2019), against an average of $2.7 million.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 116.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Foghorn Therapeutics | 352.57 Mn | 263.66 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 300,000.00 |
| Mar 31, 2021 | 300,000.00 |
| Sep 30, 2020 | 5.99 Mn |
| Dec 31, 2019 | 4.15 Mn |